# Ectodysplasin-A (EDA) Signaling Cross-Talk in Skeletogenesis

**Authors:** Ehsan Pashay Ahi, Jacqueline Moustakas-Verho, Pooja Singh

PMC · DOI: 10.1007/s00223-026-01502-0 · Calcified Tissue International · 2026-03-09

## TL;DR

This review explores how the EDA signaling pathway interacts with other molecular pathways to shape skeletal development in vertebrates.

## Contribution

The paper provides a conceptual framework for how EDA integrates with other pathways through shared transcriptional hubs to influence skeletal diversity.

## Key findings

- EDA signaling interacts with BMP, Hedgehog, Wnt, and FGF pathways during skeletal development.
- The physiological role of EDA is context-dependent, varying by interacting pathway, cell type, and developmental stage.
- EDA integrates signals through transcriptional hubs like NF-κB and NFATc1 to regulate skeletal morphogenesis.

## Abstract

Skeletal morphogenesis is a highly complicated interaction cascade of molecular cues, with the Ectodysplasin-A (EDA) pathway emerging as a potentially important contributor to this biological process. This review focuses on the molecular complexity of the EDA pathway’s role in shaping the diverse skeletal architectures observed in vertebrate models studied to date, particularly in fish and mammals. At the molecular level, we first discuss the signaling cascades initiated by EDA and briefly explore its impact on skeletal development. Insights into the transcriptional regulation and downstream effectors activated by EDA provide a greater understanding of its influence on skeletal formation. Beyond its standalone role in skeletogenesis, the review mainly focuses on the dynamic cross-talk between the EDA pathway and other important skeletogenic/morphogenic pathways. The multi-layered interplay with signaling networks, such as BMP, Hedgehog, Wnt, and FGF, highlights the integration of this pathway into broader molecular process governing skeletal morphogenesis. The physiological role of EDA in skeletal tissues appears highly context-dependent, varying with the interacting pathway, cell type, and developmental stage. We explore instances where EDA acts as a conductor, harmonizing its effects with those of other pathways to achieve distinct outcomes in skeletal diversity, and propose a conceptual framework in which EDA integrates these inputs through shared transcriptional hubs, notably NF-κB and NFATc1, in a tissue- and stage-specific manner. By summarizing the interactions of EDA and their associated physiological roles, we provide a comprehensive perspective on the EDA-dependent molecular underpinnings of skeletal diversity, offering new and valuable insights for future research and potential applications in skeletal biology.

## Linked entities

- **Genes:** EDA (ectodysplasin A) [NCBI Gene 1896], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], NFATC1 (nuclear factor of activated T cells 1) [NCBI Gene 4772]

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, RYK (receptor like tyrosine kinase) [NCBI Gene 6259] {aka D3S3195, JTK5, JTK5A, RYK1}, EDARADD (EDAR associated via death domain) [NCBI Gene 128178] {aka CR, ECTD11A, ECTD11B, ED3, EDA3}, CTSK (cathepsin K) [NCBI Gene 1513] {aka CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD}, SOST (sclerostin) [NCBI Gene 50964] {aka CDD, DAND6, SOST1, VBCH}, ORAI1 (ORAI calcium release-activated calcium modulator 1) [NCBI Gene 84876] {aka CRACM1, IMD9, ORAT1, TAM2, TMEM142A}, HEY (hairy ears, Y-linked) [NCBI Gene 100188776], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Igfbp5 (insulin-like growth factor binding protein 5) [NCBI Gene 16011] {aka IGFBP-5, IGFBP-5P}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, PTCH1 (patched 1) [NCBI Gene 5727] {aka BCNS, BCNS1, NBCCS, PTC, PTC1, PTCH}, WNT10A (Wnt family member 10A) [NCBI Gene 80326] {aka ECTD16, OODD, SSPS, STHAG4}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, GLI1 (GLI family zinc finger 1) [NCBI Gene 2735] {aka GLI, PAPA8, PPD1}, TRAP [NCBI Gene 100187907], ESR2 (estrogen receptor 2) [NCBI Gene 2100] {aka ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2}, JUN (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3725] {aka AP-1, AP1, c-Jun, cJUN, p39}, CAMK4 (calcium/calmodulin dependent protein kinase IV) [NCBI Gene 814] {aka CaMK IV, CaMK-GR, CaMKIV, caMK}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, BAMBI (BMP and activin membrane bound inhibitor) [NCBI Gene 25805] {aka NMA}, HSPG2 (heparan sulfate proteoglycan 2) [NCBI Gene 3339] {aka HSPG, PLC, PRCAN, SJA, SJS, SJS1}, WNT3A (Wnt family member 3A) [NCBI Gene 89780], WNT10B (Wnt family member 10B) [NCBI Gene 7480] {aka SHFM6, STHAG8, WNT-12}, CAMK2G (calcium/calmodulin dependent protein kinase II gamma) [NCBI Gene 818] {aka CAMK, CAMK-II, CAMKG, MRD59}, SMO (smoothened, frizzled class receptor) [NCBI Gene 6608] {aka CRJS, FZD11, Gx, PHLS, SMOH}, LEF1 (lymphoid enhancer binding factor 1) [NCBI Gene 51176] {aka ECTD1, ECTD17, LEF-1, TCF10, TCF1ALPHA, TCF7L3}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, PTHLH (parathyroid hormone like hormone) [NCBI Gene 5744] {aka BDE2, HHM, PLP, PTHR, PTHRP}, IHH (Indian hedgehog signaling molecule) [NCBI Gene 3549] {aka BDA1, HHG2}, CYP26B1 (cytochrome P450 family 26 subfamily B member 1) [NCBI Gene 56603] {aka CYP26A2, P450RAI-2, P450RAI2, RHFCA}, PAX9 (paired box 9) [NCBI Gene 5083] {aka STHAG3}, Eda (ectodysplasin-A) [NCBI Gene 13607] {aka EDA1, Ed1, Eda-A1, Eda-A2, HED, Ta}, EDN1 (endothelin 1) [NCBI Gene 1906] {aka ARCND3, ET1, HDLCQ7, PPET1, QME}, BMP2 (bone morphogenetic protein 2) [NCBI Gene 650] {aka BDA2, BMP2A, SSFSC, SSFSC1}, HTR2B (5-hydroxytryptamine receptor 2B) [NCBI Gene 3357] {aka 5-HT(2B), 5-HT-2B, 5-HT2B}, SP7 (Sp7 transcription factor) [NCBI Gene 121340] {aka OI11, OI12, OSX, osterix}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, EDA2R (ectodysplasin A2 receptor) [NCBI Gene 60401] {aka EDA-A2R, EDAA2R, TNFRSF27, XEDAR}, WNT4 (Wnt family member 4) [NCBI Gene 54361] {aka SERKAL, WNT-4}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, GREM2 (gremlin 2, DAN family BMP antagonist) [NCBI Gene 64388] {aka CKTSF1B2, DAND3, PRDC, STHAG9}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, NOTCH1 (notch receptor 1) [NCBI Gene 4851] {aka AOS5, AOVD1, TAN1, hN1}, Igfbp3 (insulin-like growth factor binding protein 3) [NCBI Gene 16009] {aka IGFBP-3, IGgfbp3}, CALM1 (calmodulin 1) [NCBI Gene 801] {aka CALML2, CAM2, CAM3, CAMB, CAMC, CAMI}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}, EDAR (ectodysplasin A receptor) [NCBI Gene 10913] {aka DL, ECTD10A, ECTD10B, ED1R, ED3, ED5}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172] {aka FRTS4, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha}, Notch3 (notch 3) [NCBI Gene 18131] {aka N3, hpbk}, MIR182 (microRNA 182) [NCBI Gene 406958] {aka MIRN182, miRNA182, mir-182}, ROR2 (ROR family WNT receptor 2) [NCBI Gene 4920] {aka BDB, BDB1, NTRKR2, RRS1}, Hey1 (hairy/enhancer-of-split related with YRPW motif 1) [NCBI Gene 15213] {aka CHF2, HRT1, Herp2, Hesr1, bHLHb31, hesr-1}, RSPO2 (R-spondin 2) [NCBI Gene 340419] {aka CRISTIN2, HHRRD, TETAMS2}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, Nfatc1 (nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1) [NCBI Gene 18018] {aka 2210017P03Rik, NF-ATc, NFAT2, NFATc, Nfatcb}
- **Diseases:** fracture (MESH:D050723), hereditary (MESH:D009386), developmental and morphological abnormalities (MESH:D000013), osteosarcoma (MESH:D012516), cartilage inflammation (MESH:D007249), skeletal disorders (MESH:C564967), craniofacial dysmorphism (MESH:C537512), bone resorption deficiency (MESH:D001862), skeletal abnormalities (MESH:D009139), bone and cartilage-related disorders and injuries (MESH:D002357), HED (MESH:D053358), metabolic diseases (MESH:D008659), osteoarthritis (MESH:D010003), osteoporosis (MESH:D010024), skeletal dysplasias (MESH:C535858), bone and cartilage inflammation (MESH:D010000), craniofacial and vertebral skeletal abnormalities (MESH:D019465), hypertrophy (MESH:D006984), dental deformities (MESH:D009057), ectodermal dysplasia (MESH:D004476), jaw bone diseases (MESH:D007572), skeletal-related disorders (MESH:D019973), osteopetrosis (MESH:D010022)
- **Chemicals:** phosphate (MESH:D010710), Vitamin A (MESH:D014801), NO (MESH:D009569), ATRA (MESH:D014212), Ca2 + (-), steroids (MESH:D013256), Calcium (MESH:D002118), Serotonin (MESH:D012701), tryptophan (MESH:D014364)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Oryzias latipes (Japanese medaka, species) [taxon 8090], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12971886/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12971886/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12971886/full.md

---
Source: https://tomesphere.com/paper/PMC12971886